-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

721.P1.54 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster I

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, AML, Anemias, antibodies, Biological, Coronaviruses, Leukemia, SARS-CoV-2/COVID-19, sickle cell disease, therapy sequence, viral, aplastic anemia, bacterial, bone marrow, CML, Diseases, Lymphoma (any), Non-Biological, Bone Marrow Failure, CMML, Combinations, Therapies, Adverse Events, chemotherapy, MDS, Pediatric, Hemoglobinopathies, immunodeficiency, MPN, Immune Disorders, Young Adult, Infectious Diseases, Lymphoid Malignancies, Study Population, Clinically relevant, Myeloid Malignancies, Quality Improvement , transplantation, stem cells
Saturday, December 5, 2020: 7:00 AM-3:30 PM

Hyung C. Suh, MD, PhD1, Scott D. Rowley, MD1, Sukhdeep Kaur, MD1, Brittany Lukasik1*, Phyllis McKiernan1*, Michele Boonstra, APN1*, Milissa Baker, MSN, ANP1*, Mary E Dilorenzo, APN2*, Alan Skarbnik, MD2, Themba Nyirenda, PhD1*, David H. Vesole, MD, PhD1 and Michele L. Donato, MD1

1John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
2Novant Health, Charlotte, NC

Rajni Agarwal, MD1, Kenneth I. Weinberg, MD2, Hye-Sook Kwon, PhD3*, Anne Le3*, Janel R Long-Boyle, PharmD, PhD4,5*, Donald B. Kohn, MD6, Kathryn Bradford, MD7*, Satiro De Oliveira, MD7*, Alice Bertaina, MD, PhD1, Agnieszka Czechowicz, MD, PhD1, Matt Porteus, MD, PhD1, David C Shyr, MD1*, Katja G Weinacht, MD, PhD1*, Ami J Shah, MD1, Melissa Mavers, MD, PhD1, Elisabeth Merkel, RN1*, Janice W Brown, MD3, Christopher C. Dvorak, MD4, Robertson Parkman, MD1, Maria Grazia Roncarolo, MD1 and Judith A Shizuru, MD, PhD1,8

1Division of Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University Medical Center, Stanford, CA
2Department of Pediatrics/Division of Stem Cell Transplantation and Regenerative Medicine, Stanford School of Medicine, palo Alto, CA
3Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University Medical Center, Stanford, CA
4Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California, San Francisco, Benioff Children's Hospital, San Francisco, CA
5Department of Clinical Pharmacy, University of California, San Francisco, Benioff Children’s Hospital, San Francisco, CA
6Broad Stem Cell Research Center, University of California - Los Angeles, Los Angeles, CA
7Division of Hematology/Oncology, Department of Pediatrics, University of California, Los Angeles, Los Angeles, CA
8Division of Blood and Marrow Transplantation, Stanford University, Stanford, CA

Rohtesh S. Mehta, MD, MPH, MS1, Roland Bassett2*, Julianne Chen3*, Benigno C. Valdez, PhD1, Jitesh Kawedia, BPharm4*, Amin M. Alousi, MD5, Gheath Alatrash6, Qaiser Bashir, MD1, Stefan Ciurea, MD7, Chitra Hosing, MD8, Jin S. Im1, Partow Kebriaei, MD8, Amanda L. Olson1, Betul Oran, MD, MS9, Muzaffar H. Qazilbash, MD8, Samer A. Srour, MD, MS1, Elizabeth J. Shpall, MD8, Borje S. Andersson, M.D., Ph.D.10, Richard E. Champlin, MD8 and Uday R. Popat, MD1

1Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
3The University of Texas MD Anderson Cancer Center, Houston, TX
4The University of Texas MD Anderson Cancer Center, Houston
5Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX
6MD Anderson Cancer Center, Houston, TX
7University of California, Irvine, Orange, CA
8Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
9Stem Cell Transplantation and Cellular Therapy, The University of Texas, MD Anderson Cancer Center, Houston, TX
10Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX

Sabine Furst1*, Valerio Maisano, MD1*, Agnes Basire2*, Angela Granata, MD1*, Faezeh Legrand, MD3*, Raynier Devillier1*, Samia Harbi1*, Luca Castagna, MD1*, Christophe Picard2*, Claude Lemarie, Pharm.D.1*, Christian Chabannon, MD, PhD1,4 and Didier Blaise, MD5

1Institut Paoli Calmettes, Marseille, France
2Etablissement Français du Sang, Marseille, France
3Hematology department, Institut Paoli Calmettes, Marseille, France
4Cell Therapy Facility, Paoli Calmettes Institute, Marseille, France
5Institut Paoli-Calmettes, Aix Marseille Univ, CNRS, INSERM, CRCM, Marseille, France

Raheel Iftikhar, FCPS, MBBS1*, Qamar Un Nisa Chaudhry, FCPS2*, Syed Kamran Mahmood, FCPS2, Tariq Ghafoor, FCPS1*, Nighat Shahbaz, FCPS1*, Mehreen Ali Khan, MBBS1, Tariq Khattak2*, Ghassan Shamshad, MBBS, FCPS2*, Jahanzeb Rehman3*, Muhammad Farhan, MBBS2*, Tariq Mahmood Satti, FCPS4* and Parvez Ahmed, FCPS5

1AF Bone Marrow Transplant Centre/NIBMT, Rawalpindi, Pakistan
2AFBMTC/NIBMT, Rawalpindi, Pakistan
3AF bone marrow transplant Centre, Rawalpindi, Pakistan
4Shifa international Hospital, islamabad, Pakistan
5Quaid-e-Azam international hospital, islamabad, Pakistan

Genevieve Douglas, B.App.Sc MBBS FRACP FRCPA1*, Michelle K Yong, MBBS, FRACP, MPH, PhD2,3,4*, Shio Yen Tio, MBBS, FRACP3,4*, Maggie Chau, BPharm(Hons) MClinPharm MBusMgt BCOP5*, Joe Sasadeusz, MBBS FRACP PhD4*, Monica Slavin, MBBS FRACP2,3,4*, Mingdi Xie, BNurs GradDip1*, David Ritchie, MB ChB, PhD, FRACP, FRCPA2,6 and Lynette C.Y. Chee, MBBS, PhD, FRACP, FRCPA1

1Clinical Haematology and Bone Marrow Transplant Service, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia
2Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia
3National Centre for Infections in Cancer, Melbourne, Australia
4Department of Infectious Diseases, Royal Melbourne Hospital, Melbourne, Australia
5Pharmacy Department, The Royal Melbourne Hospital, Melbourne, VIC, Australia
6Department of Clinical Haematology and Bone Marrow Transplant Service, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia

Yanzhi Song, MD1*, Zhichao Yin2*, Erhui Yuan1*, Yajing Wang1* and Tong Wu, MD1

1Department of Bone Marrow Transplantation, Beijing Boren Hospital, Beijing, China
2Department of Hematology, Beijing Boren Hospital, Beijing, China

Yi-Bin Chen, MD1, Dana D Lee, PharmD2*, Hayley Lane3*, Steve Smith4*, Yasuyuki Ishii, PhD5 and Lazaros J. Lekakis, MD6*

1Bone Marrow Transplant Program, Massachussets General Hospital Cancer Center, Boston, MA
2Medical Affairs 360, LLC, Carlsbad, CA
3REGiMMUNE, San Francisco, CA
4Regimmune, San Franciso, CA
5REGiMMUNE corporation, Yokohama, Japan
6University of Miami, Sylvester Comprehensive Care Center, Miami, FL

Sanjeet S Dadwal, MD1, Dongyun Yang, PhD2*, Bernard Tegtmeier3*, Vinod A. Pullarkat, MD4, Sally Mokhtari, PhD5, Joycelynne Palmer, PhD2*, Jana Dickter, MD1*, John Zaia, MD6*, David S Snyder, MD4, Deepa Nanayakkara, MD1*, Amandeep Salhotra, MD4, Alfredo Puing, MD1*, Ricardo Spielberger, MD7,8*, Karamjeet S. Sandhu, MD4, Anthony S. Stein, MD4, Randy Taplitz, MD1*, Eileen P. Smith, MD4, Stephen J. Forman, MD9, Monzr M. Al Malki, MD4 and Ryotaro Nakamura, M.D.4

1Division of Infectious Disease, City of Hope National Medical Center, Duarte, CA
2Department of Computational and Quantitative Medicine-BRI, City of Hope National Medical Center, Duarte, CA
3Division of Infectious Disease, City of Hope, Duarte, CA
4Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
5Department of Clinical Translational Project Development, City of Hope, Duarte, CA, City of Hope National Medical Center, Duarte, CA
6Center for Gene Therapy, Hematological Malignancy and Stem Cell Transplantation Institute, City of Hope National Medical Center, Duarte, CA
7Bone Marrow Transplant Program, Southern California Kaiser Permanente, Los Angeles, CA
8Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA
9Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA

Lip Leong Chong, MD, MRCP1*, Yang Liang Boo, MD1*, Yin Jie Koh1*, Michelle Poon, MBBS, MRCP, FRCPATH1*, Yeh Ching Linn, MBBS, MRCP2*, William YK Hwang, MBBS2, Aloysius YL Ho, MBBS, FRCP, FRCPath2, Elson Neo3*, Lip Kun Tan, MBBS, FRCP, FRCPath1* and Liang Piu Koh, MBBS, MRCP1*

1Department of Haematology­-Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore
2Department of Hematology, Singapore General Hospital, Singapore, Singapore
3National University of Singapore, Singapore, Singapore

Kevin Brown, MD, BA and Kristjan Paulson, MD

CancerCare Manitoba, University of Manitoba, Winnipeg, MB, Canada

Clarisse MARTINS Machado, MD, PhD1*, Mariana Nassif Kerbauy, MD2*, Iago Colturato, MD3*, Leonardo Javier Arcuri4, Ana Cláudia Ferrari dos Santos, MSc3*, Fernanda Rodrigues Silva, MD3*, Anderson João Simioni3*, Juliana Folloni Fernandes, MD5*, Mair Pedro de Souza, MD6*, Vergilio Rensi Colturato, MD7* and Nelson Hamerschlak, MD, PhD8

1Instituto Israelita de Ensino e Pesquisa, Hospital Israelita Albert Einstein, São Paulo, Brazil
2Hospital Albert EInstein / HSCT Program, Hospital Israelita Albert Einstein, São Paulo, BRA
3Hospital Amaral Carvalho / HSCT Program, Hospital Amaral Carvalho, Jahu, Brazil
4Hospital Albert Einstein / HSCT Program, Hospital Albert Einstein, São Paulo, RJ, BRA
5Department of Hematology and Bone Marrow Transplantation, Hospital Israelita Albert Einstein, Hematology unit, São Paulo, Brazil
6Hospital Amaral Carvalho / HSCT Program, Hospital Amaral Carvalho, Jahu, BRA
7Hospital Amaral Carvalho, Jaú, SP, Brazil
8Hospital Israelita Albert Einstein, Sao Paulo, Brazil

Dilan A Patel, MD1, Josu de la Fuente2, Michael Matheney, MD3*, Leena Karnik, FRCPath, MRCP4*, Heidi Chen, PhD5*, Katie S. Gatwood, PharmD6*, Kathryn A. Culos, PharmD6*, Karina L Wilkerson, NP, MSN7*, Michael T. Byrne, DO8, Salyka M. Sengsayadeth, MD9*, Stacey Ann Goodman, MD10, Bhagirathbhai Dholaria, MBBS11, Bipin N. Savani, MD12, Wichai Chinratanalab, MD9, Reena Jayani, MD13, Jim Connelly, MD14*, Carrie Lynn Kitko, MD15, Brian G. Engelhardt, MD16 and Adetola A. Kassim, MD, MS9

1Department of Hematology and Bone Marrow Transplant, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN
2Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
3University of Tennessee Health Science Center, Nashville, TN
4Department of Paediatrics, St. Mary's Hospital, London, United Kingdom
5Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN
6Department of Pharmacy, Vanderbilt University Medical Center, Nashville, TN
7Hematology/Oncology Department Sickle Cell Disease Center of Excellence, Vanderbilt University Medical Center, Nashville, TN
8Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN
9Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN
10Vanderbilt University Medical Center, Nashville, TN
11Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical center, Nashville, TN
12Department of Medicine, Division of Hematology-Oncology, Vanderbilt University, Brentwood, TN
13Vanderbilt University Medical Center, Tampa, FL
14Department of Pediatrics/Div of Hematology/Oncology, Vanderbilt University, Nashville, TN
15Vanderbilt University Medical Center, Franklin, TN
16Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Brentwood, TN

Jennifer N Saultz, DO1, Kaycee Moshofsky, BS2, Andy Kaempf, MS3*, Guang Fan, MD, PhD4, Gabrielle Meyers5*, Rachel J. Cook, MD6, Richard T. Maziarz, MD6, Peggy Appel1*, Francisco Tria, MD7* and Staci Williamson, MS6*

1Oregon Health & Science University, Portland, OR
2OHSU, Portland, OR
3Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health & Science University, Portland, OR
4Department of Pathology, Oregon Health and Science University, Portland, OR
5OHSU, Ctr. for Hem. Malignancies, Portland, OR
6Knight Cancer Institute, Oregon Health and Science University, Portland, OR
7OHSU, portland, OR

Dat Ngo, PharmD1*, Stephanie Mac, PharmD1*, Dongyun Yang, PhD2*, Saloomeh Mokhtari3, Jason Chen, PharmD1*, Haris Ali, MD4, Shukaib Arslan, MD4, Amandeep Salhotra, MD5, Thai Cao, MD4*, Nicole Karras, MD6*, Ibrahim Aldoss, M.D.4, Pkoller Koller, MD7, Andrew S. Artz, MD, MS8, Ahmed Aribi, MD9*, Karamjeet S. Sandhu, MD4, Chatchada Karanes10, Samer Khaled, MD11, Vinod A. Pullarkat, MD4, Anthony S. Stein, MD4, Guido Marcucci, MD4, Eileen P. Smith, MD4, Stephen J. Forman, MD4, David S Snyder, MD4, Ryotaro Nakamura, M.D.4 and Monzr M. Al Malki, MD4

1Pharmacy, City of Hope National Medical Center, Duarte, CA
2Department of Computational and Quantitative Medicine-BRI, City of Hope National Medical Center, Duarte, CA
3Department of Clinical Translational Project Development, City of Hope, Duarte, CA, City of Hope National Medical Center, Duarte, CA
4Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
5Department of Hematology/HCT, City of Hope, Pasadena, CA
6Department of Pediatrics, City of Hope National Medical Center, Duarte, CA
7Department of Hematology/HCT, City of Hope, Duarte, CA
8City of Hope, Duarte, CA
9City of Hope National Medical Center, Duarte, CA
10Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA
11Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA

Muhammad Farhan, MBBS1,2*, Qamar Un Nisa Chaudhry, FCPS1,3*, Syed Kamran Mahmood, FCPS1, Tariq Ghafoor, FCPS4*, Raheel Iftikhar, FCPS, MBBS4*, Nighat Shahbaz, FCPS4*, Mehreen Ali Khan, MBBS4, Tariq Khattak1*, Ghassan Shamshad, MBBS, FCPS1*, Jahanzeb Rehman, FCPS1* and Parvez Ahmed, FCPS5

1AFBMTC/NIBMT, Rawalpindi, Pakistan
2AFBMTC, CMH, Rawalpindi, Pakistan
3Armed Forces Bone Marrow Transplant Centre, Rawalpindi, Pakistan
4AF Bone Marrow Transplant Centre/NIBMT, Rawalpindi, Pakistan
5Quaid-e-Azam international hospital, islamabad, Pakistan

Alessia Fraccaroli, MD1*, Sarah Haebe, MD2*, Heidrun Drolle1*, Elena Stauffer, Elena.Stauffer@med.uni-muenchen.de3*, Veit Buecklein, MD4*, Dusan Prevalsek5*, Michael von Bergwelt, MD, PhD1* and Johanna Tischer6*

1Department of Medicine III, University Hospital of Munich-Grosshadern, Ludwig-Maximilians University, Munich, Germany, Munich, Germany
2Department of Medicne III, University Hospital Munich, Muenchen, Germany
3Department of Medicine III, University Hospital of Munich-Grosshadern, LMU, Munich, Germany
4Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
5Department of Medicine III, University Hospital of Munich-Grosshadern, Ludwig-Maximilians University, Munich, Germany, Munich, DEU
6Department of Internal Medicine III, University Hospital of Munich-Grosshadern, Ludwig-Maximilians University, Munich, Germany, Munich, Germany

Arshia Akbar, MD, MBBS1*, Zunairah Shah, MBBS2*, Muhammad Ali Aziz, MD3*, Muhammad Yasir Anwar4*, Saman Bahram5*, Waqas Khan6*, Zahoor Ahmed, MD4*, Qasim Khurshid, MD7*, Abdul Jabbar Dar, MD8*, Anum Javaid, MD9*, Neelam Asghar10*, Harsh Patel11* and Faiz Anwer, MD12

1Holy Family Hospital, Rawalpindi, Pakistan
2Department of Internal Medicine, Louis A Weiss Memorial Hospital, Chicago, IL
3King Edward Medical University, Lahore, Pakistan
4Department of Internal Medicine, King Edward Medical University, Lahore, Pakistan
5Dow university of Health Sciences, karachi, Pakistan
6Army medical College, Rawalpindi, Pakistan
7Xinjiang Medical University, Urumqi, China
8Shaikh Zayed Medical College, Lahore, Pakistan
9rawalpindi medical university, rawalpindi, Pakistan
10allama iqbal medical college, lahore, Pakistan
11Department of Internal Medicine, Louis A Weiss memorial hospital, chicago
12Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH

Tamar Berger, MD1,2*, Odil Giladi, MD2*, Dafna Yahav, MD1,3*, Haim Ben-Zvi1,4*, Oren Pasvolsky, MD1,2*, Liat Shargian-Alon, MD1,2*, Ofir Wolach, MD1,2*, Uri Rozovski, MD1,2, Pia Raanani, MD1,5 and Moshe Yeshurun, MD1,2*

1Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel
2Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel
3Infectious Disease Unit, Rabin Medical Center, Petah-Tikva, Israel
4Microbiologic Laboratory, Rabin Medical Center, Petah-Tikva, Israel
5Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel

Atul Sathe, MS1*, Mark Knapp1*, Peter Kim1*, Lihong Zhao1*, Xavier-Charles Leber2*, Andreas Hein2*, Meike Scharenberg2*, Jacob Shaul1*, Kelly Wong1*, Steven J Kovacs3*, Elisabetta Traggiai4*, Amy K Patick5* and Johanna R Abend1*

1Novartis Institutes for BioMedical Research, Infectious Disease Area, Emeryville, CA
2Novartis Institutes for BioMedical Research, Biologics, Basel, Switzerland
3Novartis Institutes for BioMedical Research, Translational Medicine, East Hanover, NJ
4Novartis Institute For Research In Biomedicine, Basel, CHE
5Amplyx Pharmaceuticals, Inc, San Diego, CA

Asmaa Ferdjallah, MD, MPH1*, Kristina M Nelson, PharmD1*, Kailey Meyer, BA1*, Cathryn A Jennissen, PharmD1* and Christen L. Ebens, MD, MPH2

1University of Minnesota, Minneapolis, MN
2Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN

Cynthia Pelayo Mena, M.D.1*, Luis Manuel Valero Saldaña, MD2*, Brenda Lizeth Acosta-Maldonado, MD2*, Dana Perez Camargo, MSc3* and Victor Itaí Urbalejo Ceniceros, MD, MSc4

1Hematology Department, Instituto Nacional de Cancerología, Mexico City, Mexico
2Stem Cell Transplantation Program, Instituto Nacional de Cancerologia, Mexico City, Mexico
3Instituto Nacional de Cancerología, Mexico City, Mexico
4Hematology Department, Instituto Nacional de Cancerología, México, DF, Mexico

Arata Ishii1*, Akira Yokota, MD, PhD2*, Emiko Sakaida, MD, PhD1, Shokichi Tsukamoto, MD, PhD1, Katsuhiro Shono, MD, PhD2*, Takashi Toya, MD, PhD3, Yuho Najima, MD, PhD3, Takeshi Kobayashi, MD3, Noriko Doki, MD, PhD3*, Hideki Nakasone, MD, PhD4, Shinichi Kako, MD4, Takayoshi Tachibana, MD5*, Masatsugu Tanaka, MD5*, Nobuyuki Aotsuka, MD, PhD6*, Toru Sakura, PhD, MD7*, Shingo Yano, MD, PhD8, Shin Fujisawa, MD9*, Yuki Shiko10*, Yohei Kawasaki10*, Chiaki Nakaseko, MD, PhD11 and Yoshinobu Kanda, MD, PhD12,13

1Department of Hematology, Chiba University Hospital, Chiba, Japan
2Department of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan
3Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
4Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
5Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan
6Department of Hematology and Oncology, Japanese Red Cross Narita Hospital, Narita, Japan
7Leukemia Research Center, Saiseikai Maebashi Hospital, Maebashi, Japan
8Division of Clinical Oncology and Hematology, Jikei University School of Medicine, Tokyo, Japan
9Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan
10Biostatistics Section, Clinical Research Center, Chiba University Hospital, Chiba, Japan
11Department of Hematology, International University of Health and Welfare, Narita, Japan
12Jichi Medical University, Shimotsuke, Japan
13Kanto Study Group for Cell Therapy, Tokyo, Japan

Naveed Ali, MD1, Ana Carolina Pires de Rezende, MD2*, Folashade Otegbeye, MBBChir, MPH3, Mariana Nassif Kerbauy, MD4*, Brenda W. Cooper, MD3, David Mansur, MD5*, Gisele Pereira, PhD5*, Roberto Sakuraba, MD2*, Benjamin K. Tomlinson, MD3, Kirsten M Boughan, DO3, Cinthya Correa Silva, MD6*, Leland Metheny III, MD3, Andreza Feitosa Ribeiro, MD7, Molly M Gallogly, MD, PhD3, Ehsan Malek, MD8, EDuardo Weltman, MD6*, Marcos de Lima, MD3, Nelson Hamerschlak, MD, PhD9 and Paolo F Caimi, MD3

1Case Western Reserve University, University Heights, OH
2Department of Radiation Oncology, Hospital Israelita Albert Einstein, São Paulo, Brazil
3Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Cleveland, OH
4Hospital Albert EInstein / HSCT Program, Hospital Israelita Albert Einstein, São Paulo, BRA
5Department of Radiation Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH
6Oncology and Hematology, Hospital Israelita Albert Einstein, São Paulo, Brazil
7Hospital Israelita Albert Einstein, Sao Paulo, Sp, BRA
8Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Shaker Hts, OH
9Hematology, Hospital Israelita Albert Einstein, São Paulo, Brazil

Madhavi Lakkaraja, MD, MPH1, Michael Scordo, MD2,3, Audrey Mauguen, PhD4*, Christina Cho, MD2,3, Sean Devlin, PhD4*, Scott T Avecilla, MD PhD5*, Farid Boulad, MD1, Maria I. Cancio, MD1, Kevin J. Curran, MD1, Ann A. Jakubowski, MD PhD2,3, Nancy A. Kernan1, Andrew L. Kung, MD, PhD1, Richard J O'Reilly, MD1, Esperanza B. Papadopoulos, MD2,3, Susan Prockop, MD1, Ichelle Roessel1*, Josel D Ruiz, MPH2*, Andromachi Scaradavou, MD1*, Brian C. Shaffer, MD2, Gunjan Shah, MD2,3*, Barbara Spitzer, MD1, Roni Tamari, MD2,3, Sergio A. Giralt, MD2,3, Miguel-Angel Perales, MD2,3 and Jaap Jan Boelens, MD, PhD1

1Department of Pediatrics, BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Medicine, Weill Cornell Medical College, New York, NY
4Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
5Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Maria Alejandra Pereda, MD1, Sindhoosha Malay, MPH, PharmD2* and Jignesh Dalal, MD3

1University Hospitals Rainbow Babies & Children's Hospital, Cleveland, OH
2School of Medicine, Case Western Reserve University, Cleveland, OH
3Rainbow Babies & Children's Hospital, Cleveland, OH

*signifies non-member of ASH